Health Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients Posted on March 7, 2024 by miyuru Oncology/Hematology > Lymphoma — Talk of possible treatment for some clients with brentuximab plus dacarbazine or nivolumab by Charles BankheadSenior Editor, MedPage Today March 6, 2024 Older clients with classical….
